Foresight Diagnostics Stock

Foresight Diagnostics develops novel technology for detect cancers from a simple blood draw.

Sign up today and learn more about Foresight Diagnostics Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About Foresight Diagnostics Stock

Foresight Diagnostics develops a novel liquid biopsy test for the measurement of minimal residual disease to aid in patient management. They garnered significant partnering interest from multiple pharmaceutical companies in oncology.

Funding History

June 2021$12.5M
April 2023$58.8M

Management

Chief Operations Officer

Sandra Close

Founder

Maximilian Diehn

Board Member

Uplaksh Kumar

Founder

David Kurtz

Scientific Co-Founder

Ash Alizadeh

CEO, CSO & Founder

Jake Chabon

Scientific Advisor & Board Member

Maximilian Diehn

Scientific Advisor

David Kurtz

CFO and CBO

Mukul Agarwal

Press

Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Logo